These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30153487)

  • 1. Acrylic microparticles increase daptomycin intracellular and in vivo anti-biofilm activity against Staphylococcus aureus.
    Woischnig AK; Gonçalves LM; Ferreira M; Kuehl R; Kikhney J; Moter A; Ribeiro IAC; Almeida AJ; Khanna N; Bettencourt AF
    Int J Pharm; 2018 Oct; 550(1-2):372-379. PubMed ID: 30153487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation in Polymeric Microparticles Improves Daptomycin Activity Against Mature Staphylococci Biofilms-a Thermal and Imaging Study.
    Santos Ferreira I; Kikhney J; Kursawe L; Kasper S; Gonçalves LMD; Trampuz A; Moter A; Bettencourt AF; Almeida AJ
    AAPS PharmSciTech; 2018 May; 19(4):1625-1636. PubMed ID: 29488195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
    Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
    Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible daptomycin tolerance of adherent staphylococci in an implant infection model.
    John AK; Schmaler M; Khanna N; Landmann R
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3510-6. PubMed ID: 21576433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations about the Use of a Loading Dose of Daptomycin in a Neutropenic Murine Thigh Infection Model with Methicillin-Resistant Staphylococcus aureus Infection.
    Kato H; Hagihara M; Murakami E; Suematsu H; Nishiyama N; Koizumi Y; Yamagishi Y; Uno B; Mikamo H
    Chemotherapy; 2018; 63(1):13-19. PubMed ID: 29130946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.
    Ferreira IS; Bettencourt AF; Gonçalves LM; Kasper S; Bétrisey B; Kikhney J; Moter A; Trampuz A; Almeida AJ
    Int J Nanomedicine; 2015; 10():4351-66. PubMed ID: 26185439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.
    Mihailescu R; Furustrand Tafin U; Corvec S; Oliva A; Betrisey B; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2014 May; 58(5):2547-53. PubMed ID: 24550327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.
    Niska JA; Shahbazian JH; Ramos RI; Pribaz JR; Billi F; Francis KP; Miller LS
    Antimicrob Agents Chemother; 2012 May; 56(5):2590-7. PubMed ID: 22371896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin exerts differential immunomodulatory effects on host responses against methicillin-resistant Staphylococcus aureus biofilms.
    Simitsopoulou M; Kadiltzoglou P; Antachopoulos C; Roilides E
    Int J Antimicrob Agents; 2022 Oct; 60(4):106666. PubMed ID: 36038095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics.
    Lefèvre S; Saleh M; Marcellin L; Subilia A; Bourcier T; Prévost G; Jehl F
    Antimicrob Agents Chemother; 2012 May; 56(5):2485-92. PubMed ID: 22371888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model.
    Estellés A; Woischnig AK; Liu K; Stephenson R; Lomongsod E; Nguyen D; Zhang J; Heidecker M; Yang Y; Simon RJ; Tenorio E; Ellsworth S; Leighton A; Ryser S; Gremmelmaier NK; Kauvar LM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2292-301. PubMed ID: 26833157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus.
    El Haj C; Murillo O; Ribera A; Vivas M; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Int J Antimicrob Agents; 2015 Aug; 46(2):189-95. PubMed ID: 26051988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
    Meije Y; Almirante B; Del Pozo JL; Martín MT; Fernández-Hidalgo N; Shan A; Basas J; Pahissa A; Gavaldà J
    J Infect; 2014 Jun; 68(6):548-52. PubMed ID: 24412247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound.
    Pierpaoli E; Orlando F; Cirioni O; Simonetti O; Giacometti A; Provinciali M
    Phytomedicine; 2017 Dec; 36():50-53. PubMed ID: 29157827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
    J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.